Michael Goedken

3.3k total citations
72 papers, 2.5k citations indexed

About

Michael Goedken is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Michael Goedken has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Michael Goedken's work include Drug Transport and Resistance Mechanisms (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Drug-Induced Hepatotoxicity and Protection (13 papers). Michael Goedken is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Drug-Induced Hepatotoxicity and Protection (13 papers). Michael Goedken collaborates with scholars based in United States, Netherlands and Czechia. Michael Goedken's co-authors include Lauren M. Aleksunes, José E. Manautou, Curtis D. Klaassen, Sylvain De Guise, Nathan J. Cherrington, Phoebe A. Stapleton, Sara Fournier, Laura Fabris, Jeanine N. D’Errico and Edward J. Yurkow and has published in prestigious journals such as Gastroenterology, The Science of The Total Environment and Hepatology.

In The Last Decade

Michael Goedken

71 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Goedken United States 29 698 644 452 450 395 72 2.5k
María Concepción Gutiérrez‐Ruíz Mexico 34 722 1.0× 199 0.3× 159 0.4× 576 1.3× 264 0.7× 118 2.8k
Bhagavatula Moorthy United States 35 1.3k 1.9× 350 0.5× 741 1.6× 146 0.3× 235 0.6× 152 4.2k
Guang Yang China 28 1.1k 1.5× 96 0.1× 130 0.3× 312 0.7× 213 0.5× 91 2.5k
Pan Chen China 27 814 1.2× 417 0.6× 394 0.9× 286 0.6× 58 0.1× 76 2.4k
Jan Vondráček Czechia 39 1.2k 1.8× 342 0.5× 233 0.5× 118 0.3× 463 1.2× 141 4.0k
Carlo Rossetti Italy 29 910 1.3× 478 0.7× 39 0.1× 140 0.3× 492 1.2× 86 3.7k
Charles O. Abernathy United States 20 415 0.6× 252 0.4× 229 0.5× 87 0.2× 300 0.8× 57 2.3k
Matthew C. Cave United States 29 866 1.2× 158 0.2× 172 0.4× 1.2k 2.6× 84 0.2× 87 2.9k
Tao Peng China 28 1.1k 1.6× 529 0.8× 71 0.2× 649 1.4× 209 0.5× 176 3.4k
Jean‐Marc Lo‐Guidice France 34 1.4k 2.0× 466 0.7× 797 1.8× 141 0.3× 200 0.5× 99 3.8k

Countries citing papers authored by Michael Goedken

Since Specialization
Citations

This map shows the geographic impact of Michael Goedken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Goedken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Goedken more than expected).

Fields of papers citing papers by Michael Goedken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Goedken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Goedken. The network helps show where Michael Goedken may publish in the future.

Co-authorship network of co-authors of Michael Goedken

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Goedken. A scholar is included among the top collaborators of Michael Goedken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Goedken. Michael Goedken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polunas, Marianne, et al.. (2025). Gestational exposure to micro and nanoplastics differentially impacts cardiac development and function in male and female rats throughout the lifespan. Toxicology and Applied Pharmacology. 504. 117507–117507. 1 indexed citations
2.
Li, Hui, Joseph L. Jilek, Michael Goedken, et al.. (2024). Nonalcoholic steatohepatitis increases plasma retention of sorafenib-glucuronide in a mouse model by altering hepatocyte hopping. Acta Pharmaceutica Sinica B. 14(11). 4874–4882.
3.
4.
Doherty, Cathleen, Brian Buckley, Michael Goedken, et al.. (2023). Cadmium reduces growth of male fetuses by impairing development of the placental vasculature and reducing expression of nutrient transporters. Toxicology and Applied Pharmacology. 475. 116636–116636. 7 indexed citations
5.
Suh, Nanjoo, et al.. (2023). Isothiocyanate-rich moringa seed extract reduces skin inflammation in mouse ear edema model. Phytomedicine Plus. 3(4). 100479–100479. 4 indexed citations
6.
DeLoid, Glen M., Dimitrios Bitounis, Marianne Polunas, et al.. (2023). Ingested Polystyrene Nanospheres Translocate to Placenta and Fetal Tissues in Pregnant Rats: Potential Health Implications. Nanomaterials. 13(4). 720–720. 54 indexed citations
7.
Jilek, Joseph L., et al.. (2023). Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 51(8). 970–981. 1 indexed citations
8.
Pfohl, Marisa, Emily Marques, Benjamin Barlock, et al.. (2021). An ‘Omics Approach to Unraveling the Paradoxical Effect of Diet on Perfluorooctanesulfonic Acid (PFOS) and Perfluorononanoic Acid (PFNA)-Induced Hepatic Steatosis. Toxicological Sciences. 180(2). 277–294. 34 indexed citations
9.
Rizzolo, Daniel, Bo Kong, Anita Brinker, et al.. (2021). Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1. Acta Pharmaceutica Sinica B. 11(12). 3847–3856. 69 indexed citations
10.
Jilek, Joseph L., et al.. (2021). Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule Toxicity. Drug Metabolism and Disposition. 50(10). 1389–1395. 5 indexed citations
11.
Fournier, Sara, Jeanine N. D’Errico, Derek Adler, et al.. (2020). Nanopolystyrene translocation and fetal deposition after acute lung exposure during late-stage pregnancy. Particle and Fibre Toxicology. 17(1). 55–55. 321 indexed citations
12.
Donepudi, Ajay C., Michael Goedken, John D. Schuetz, & José E. Manautou. (2019). Lack of multidrug resistance-associated protein 4 (Mrp4) alters the kinetics of acetaminophen toxicity. Toxicology Reports. 6. 841–849. 6 indexed citations
13.
Schumacher, Justin D., Bo Kong, Yi Pan, et al.. (2017). The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. Toxicology and Applied Pharmacology. 330. 1–8. 41 indexed citations
14.
Clarke, John, Anika L. Dzierlenga, Hui Li, et al.. (2016). Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir. Biochemical Pharmacology. 115. 144–151. 10 indexed citations
15.
Xia, Wen, Brian Buckley, Elizabeth McCandlish, et al.. (2014). Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice. American Journal Of Pathology. 184(5). 1299–1308. 52 indexed citations
16.
Hardwick, Rhiannon N., John Clarke, April D. Lake, et al.. (2014). Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis. Toxicological Sciences. 142(1). 45–55. 48 indexed citations
17.
Kyriakides, Michael, Rhiannon N. Hardwick, Zhaosheng Jin, et al.. (2014). Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat. Toxicological Sciences. 142(1). 105–116. 16 indexed citations
18.
Aleksunes, Lauren M., Sarah N. Campion, Michael Goedken, & José E. Manautou. (2008). Acquired Resistance to Acetaminophen Hepatotoxicity is Associated with Induction of Multidrug Resistance-Associated Protein 4 (Mrp4) in Proliferating Hepatocytes. Toxicological Sciences. 104(2). 261–273. 60 indexed citations
19.
Campion, Sarah N., Rachel M. Johnson, Lauren M. Aleksunes, et al.. (2008). Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(2). G294–G304. 50 indexed citations
20.
Manautou, José E., Dirk R. de Waart, Cindy Kunne, et al.. (2005). Altered Disposition of Acetaminophen in Mice With a Disruption of the Mrp3 Gene * #. Hepatology. 42(5). 1091–1098. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Concepción Gutiérrez‐Ruíz Breakdown of academic impact, for papers by Bhagavatula Moorthy Breakdown of academic impact, for papers by Guang Yang Breakdown of academic impact, for papers by Pan Chen Breakdown of academic impact, for papers by Jan Vondráček Breakdown of academic impact, for papers by Carlo Rossetti Breakdown of academic impact, for papers by Charles O. Abernathy Breakdown of academic impact, for papers by Matthew C. Cave Breakdown of academic impact, for papers by Tao Peng Breakdown of academic impact, for papers by Jean‐Marc Lo‐Guidice
Rankless by CCL
2026